These functional insights into the involvement of CAV1 genetic variant rs1997623 further strengthen the concept that CAV1 contributes to MetS susceptibility and represents an attractive molecular target for the prevention and treatment of MetS. Here, CAV1 is linked to metabolic syndrome.